Benefit from a high dose of gefitinib in a woman with lung adenocarcinoma and an epidermal growth factor receptor tyrosine-kinase acquired mutation
2007 ◽
Vol 13
(3)
◽
pp. 799-805
◽
2013 ◽
Vol 74
(3)
◽
pp. 129
◽
2020 ◽
2014 ◽
Vol 35
(8)
◽
pp. 915
2016 ◽
Vol 12
(3)
◽
pp. 229-240
◽
1992 ◽
Vol 267
(21)
◽
pp. 15237-15245